Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRI | AMGN | REGN | VRTX | BMY |
| Company | Gri Bio Inc | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.5220 | 320.43 | 1,152.27 | 464.55 | 49.06 |
| High | 0.5397 | 324.36 | 1,161.21 | 471.96 | 49.29 |
| Low | 0.4750 | 319.56 | 1,138.67 | 463.51 | 48.11 |
| Last | 0.4750 | 322.73 | 1,156.86 | 471.44 | 48.41 |
| Change | -0.0389 | -0.72 | -1.47 | +3.85 | -0.65 |
| % Change | -7.57% | -0.22% | -0.13% | +0.82% | -1.32% |
| Volume | 97,500 | 1,656,100 | 443,100 | 1,068,100 | 10,667,200 |
| 20-Day Average Volume | 1,071,650 | 2,158,450 | 483,935 | 1,254,840 | 17,417,266 |
| Previous Close | 0.5139 | 323.45 | 1,158.33 | 467.59 | 49.06 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9023 | 329.20 | 1,087.78 | 484.80 | 46.65 |
| 20-Day Raw Stochastic | 3.45% | 40.09% | 96.36% | 25.48% | 71.00% |
| 20-Day Relative Strength | 21.25% | 50.39% | 68.97% | 46.52% | 60.75% |
| Weighted Alpha | -98.77 | +23.89 | +47.47 | +35.10 | -16.84 |
| Today's Opinion | 100% Sell | 72% Buy | 100% Buy | 56% Buy | 24% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 100% Buy | 56% Buy | 24% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 08/07/24 | +3.27% since 08/07/24 | +8.34% since 08/07/24 | +1.19% since 08/07/24 | +4.11% since 08/07/24 |
| Low | 0.4700 on 08/08/24 | 312.79 on 08/08/24 | 1,069.03 on 08/08/24 | 458.04 on 08/13/24 | 46.22 on 08/08/24 |
| High | 0.5398 on 08/13/24 | 325.12 on 08/08/24 | 1,161.21 on 08/14/24 | 472.66 on 08/08/24 | 49.28 on 08/14/24 |
| 1-Month | |||||
| %Chg | -72.70% since 07/12/24 | -2.45% since 07/12/24 | +5.16% since 07/12/24 | -3.54% since 07/12/24 | +19.65% since 07/12/24 |
| Low | 0.4002 on 08/05/24 | 306.59 on 08/07/24 | 1,041.85 on 08/01/24 | 458.04 on 08/13/24 | 39.92 on 07/15/24 |
| High | 2.5700 on 07/23/24 | 346.85 on 07/25/24 | 1,161.21 on 08/14/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 |
| 3-Month | |||||
| %Chg | -90.99% since 05/14/24 | +3.64% since 05/14/24 | +17.49% since 05/14/24 | +10.00% since 05/14/24 | +8.28% since 05/14/24 |
| Low | 0.4002 on 08/05/24 | 295.30 on 06/13/24 | 952.30 on 05/30/24 | 428.62 on 05/15/24 | 39.35 on 07/05/24 |
| High | 6.2374 on 05/21/24 | 346.85 on 07/25/24 | 1,161.21 on 08/14/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | -96.68% since 02/14/24 | +11.26% since 02/14/24 | +22.05% since 02/14/24 | +12.82% since 02/14/24 | -0.98% since 02/14/24 |
| Low | 0.4002 on 08/05/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.35 on 07/05/24 |
| High | 14.6900 on 02/16/24 | 346.85 on 07/25/24 | 1,161.21 on 08/14/24 | 510.64 on 08/01/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 279 | 173,509,904 | 127,631,728 | 120,663,008 | 99,449,528 |
| Shares Outstanding, K | 544 | 536,435 | 110,186 | 258,053 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 45,006,000,000 |
| Annual Net Income | -13,040,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 12,201,000,000 |
| Last Quarter Net Income | -1,890,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,680,000,000 |
| 60-Month Beta | -1.68 | 0.58 | 0.13 | 0.39 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -5.98 on 05/10/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 08/12/24 | 08/06/24 | 08/01/24 | 08/01/24 | 07/26/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | 12/19/19 | 08/16/24 | N/A | N/A | 07/05/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.20 | 29.18 | 0.00 | 34.35 |